Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Valantine

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 20, 2004
Cardiac allograft vasculopathy after heart transplantation: risk factors and managementHannah Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 5, 2007
Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncologyHannah Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2005
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trialHannah Valantine
The Journal of Investigative Dermatology|November 26, 2016
NIH's Essential 21st-Century Research Challenge: Enhancing Scientific Workforce DiversityHannah Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2005
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantationHannah Valantine, Andreas Zuckermann
Circulation|June 14, 2021
A Pioneer in Transplantation Genomics, Inclusion, and Diversity: A Conversation With Hannah Valantine, MBBS, MDHannah Valantine, Maryjane Farr
Academic Medicine : Journal of the Association of American Medical Colleges|August 24, 2013
Changing the culture of academic medicine to eliminate the gender leadership gap: 50/50 by 2020Hannah Valantine, Christy I Sandborg
Nature Medicine|November 12, 2021
A commitment to scientific equity from a philanthropic funderCori Bargmann, Anne Claiborne, Hannah Valantine
Nature|March 4, 2016
Policy: NIH push to stop sexual harassmentMichael Lauer, Hannah Valantine, Francis S Collins
Academic Medicine : Journal of the Association of American Medical Colleges|December 28, 2020
Everyday Heroism: Maintaining Organizational Cultures of Wellness and Inclusive Excellence Amid Simultaneous PandemicsMagali Fassiotto, Hannah Valantine, Tait Shanafelt, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 20, 2004
Cardiac allograft vasculopathy after heart transplantation: risk factors and managementHannah Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 5, 2007
Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncologyHannah Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2005
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trialHannah Valantine
The Journal of Investigative Dermatology|November 26, 2016
NIH's Essential 21st-Century Research Challenge: Enhancing Scientific Workforce DiversityHannah Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2005
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantationHannah Valantine, Andreas Zuckermann
Circulation|June 14, 2021
A Pioneer in Transplantation Genomics, Inclusion, and Diversity: A Conversation With Hannah Valantine, MBBS, MDHannah Valantine, Maryjane Farr
Academic Medicine : Journal of the Association of American Medical Colleges|August 24, 2013
Changing the culture of academic medicine to eliminate the gender leadership gap: 50/50 by 2020Hannah Valantine, Christy I Sandborg
Nature Medicine|November 12, 2021
A commitment to scientific equity from a philanthropic funderCori Bargmann, Anne Claiborne, Hannah Valantine
Nature|March 4, 2016
Policy: NIH push to stop sexual harassmentMichael Lauer, Hannah Valantine, Francis S Collins
Academic Medicine : Journal of the Association of American Medical Colleges|December 28, 2020
Everyday Heroism: Maintaining Organizational Cultures of Wellness and Inclusive Excellence Amid Simultaneous PandemicsMagali Fassiotto, Hannah Valantine, Tait Shanafelt, et al.
Pageof 6